Silexion Therapeutics Corp (SLXN, SLXNW)

CIK 2022416 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Silexion Therapeutics Corp.

Recent SEC filings

FiledFormAccession number
Sep 9, 2026DEFA14A0001178913-26-004466
Aug 24, 2026DEF 14A0001178913-26-004243
Aug 21, 20268-K0001178913-26-004223
Aug 19, 2026SCHEDULE 13D/A0001213900-26-091845
Aug 18, 2026SCHEDULE 13G0001213900-26-091333
Aug 14, 20268-K0001178913-26-004136
Aug 14, 202610-Q0001178913-26-004138
Aug 14, 2026PRE 14A0001178913-26-004145
Aug 13, 2026SCHEDULE 13G/A0001213900-26-088835
Aug 13, 2026424B40001178913-26-004116
Aug 13, 20268-K0001178913-26-004128
Aug 13, 20268-K0001178913-26-004122
Aug 11, 2026EFFECT9999999995-26-002627
Aug 10, 2026S-1/A0001178913-26-004003
Aug 10, 20268-K0001178913-26-003966
Aug 7, 2026S-10001178913-26-003961
Aug 4, 20268-K0001178913-26-003796
Aug 3, 20268-K0001178913-26-003761
Jul 31, 20268-K0001178913-26-003742
Jul 29, 20268-K0001178913-26-003690
Jul 21, 20268-K0001178913-26-003551
Jul 13, 2026DEFA14A0001178913-26-003465
Jun 23, 2026SCHEDULE 13D/A0001213900-26-071073
Jun 18, 2026424B30001178913-26-003253
Jun 18, 2026EFFECT9999999995-26-002070